C4 Therapeutics Appoints Thomas E. Needham, Jr., MBA As Chief Business Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--C4 Therapeutics today announced the appointment of Thomas E. Needham, Jr., MBA, to the position of Chief Business Officer. Mr. Needham joins with over 20 years of experience in venture capital, business development, corporate strategy and executive management responsibilities in public and private biotechnology companies. In this new role, Mr. Needham will lead C4 Therapeutics' corporate and business development, finance, legal and corporate communications functions.

Suggested Articles

A new clinical hold is the latest setback for Solid Biosciences and the development of its gene therapy for Duchenne muscular dystrophy.

VBI's Sci-B-Vac protected twice as many people than GSK's Engerix-B did after the second dose.

The notice comes weeks after Amgen revealed it was retreating from its East Coast neuroscience operations.